Next Article in Journal
Stability of Multicomponent Antidote Parenteral Formulations for Autoinjectors against Chemical War Agents (Neurotoxics)
Next Article in Special Issue
Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?
Previous Article in Journal
New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?
Previous Article in Special Issue
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(6), 819; https://doi.org/10.3390/pharmaceutics16060819
Action Date Notes Link
article xml file uploaded 17 June 2024 14:13 CEST Original file -
article xml uploaded. 17 June 2024 14:13 CEST Update https://www.mdpi.com/1999-4923/16/6/819/xml
article pdf uploaded. 17 June 2024 14:13 CEST Version of Record https://www.mdpi.com/1999-4923/16/6/819/pdf
article supplementary file uploaded. 17 June 2024 14:13 CEST - https://www.mdpi.com/1999-4923/16/6/819#supplementary
article html file updated 17 June 2024 14:16 CEST Original file https://www.mdpi.com/1999-4923/16/6/819/html
Back to TopTop